🇺🇸 US 실적속보 by TNBfolio

Arrowhead Pharmaceuticals, Inc. (ARWR)
시가총액: 3.21B
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://arrowheadpharma.com

- 분기 매출(공시, 예측, 서프, YoY, MoM)
2406: 50M / 52.87M / -5.4% / 216.0% / --
2403: 0.0 / -- / -- / -100.0% / -100.0%
2312: 3.55M / -- / -- / -- / -77.9%
2309: 16.1M / -- / -- / -- / 1.7%
2306: 15.82M / -- / -- / -- / -89.2%

- 분기 EPS(공시, 예측, 서프, YoY, MoM)
2406: -1.38 / -0.53 / -160.4% / -43.7% / -35.3%
2403: -1.02 / -- / -- / -326.7% / 17.7%
2312: -1.24 / -- / -- / -217.9% / --
2309: -- / -- / -- / -- / --
2306: -0.96 / -- / -- / -- / -313.3%

- 연간 매출(YoY%), EPS(YoY%)
2309: 240.74M(-1.0%) / -1.92(-15.0%)
2209: 243.23M(75.9%) / -1.67(-22.8%)
2109: 138.29M(57.2%) / -1.36(-61.9%)
2009: 87.99M(--) / -0.84(--)

#ARWR

- 사업요약: Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes Plozasiran, which is in Phase 2b and one Phase 3 clinica...

26 views뉴스크롤러, 00:17

#ARWR

Arrowhead Pharmaceuticals Fiscal Q3 Loss Widens; Secures $500 Million Credit Facility From Sixth Street
https://finance.yahoo.com/news/arrowhead-pharmaceuticals-fiscal-q3-loss-204958536.html

Arrowhead Research: Fiscal Q3 Earnings Snapshot
https://finance.yahoo.com/news/arrowhead-research-fiscal-q3-earnings-203742557.html

Arrowhead Pharmaceuticals Reports Fiscal 2024 Third Quarter Results
https://finance.yahoo.com/news/arrowhead-pharmaceuticals-reports-fiscal-2024-200100681.html

Arrowhead Pharmaceuticals Announces $500 Million Strategic Financing Facility with Sixth Street
https://finance.yahoo.com/news/arrowhead-pharmaceuticals-announces-500-million-200000675.html

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
https://finance.yahoo.com/news/arrowhead-pharmaceuticals-reports-inducement-grants-203000413.html

Yahoo Finance

Arrowhead Pharmaceuticals Fiscal Q3 Loss Widens; Secures $500 Million Credit Facility From Sixth Street

21 views뉴스크롤러, 00:17

🇺🇸 US 실적속보 by TNBfolio

Arrowhead Pharmaceuticals, Inc. (ARWR)
시가총액: 2.63B
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://arrowheadpharma.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2409: 35M / 55.07M / -36.4% / 117.4% / -30.0%
2406: 50M / 52.87M / -5.4% / 216.0% / --
2403: 0.0 / -- / -- / -100.0% / -100.0%
2312: 3.55M / -- / -- / -- / -77.9%
2309: 16.1M / -- / -- / -- / 1.7%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2409: -1.36 / -0.9704 / -40.1% / -- / 1.4%
2406: -1.38 / -0.53 / -160.4% / -43.7% / -35.3%
2403: -1.02 / -- / -- / -326.7% / 17.7%
2312: -1.24 / -- / -- / -217.9% / --
2309: -- / -- / -- / -- / --

- 연간 매출(YoY%), EPS(YoY%)
2309: 240.74M(-1.0%) / -1.92(-15.0%)
2209: 243.23M(75.9%) / -1.67(-22.8%)
2109: 138.29M(57.2%) / -1.36(-61.9%)
2009: 87.99M(--) / -0.84(--)

#ARWR

- 사업요약: Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes Plozasiran, which is in Phase 2b and one ...

246 views00:06

🇺🇸 US 실적속보 by TNBfolio

#ARWR

Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 Billion Deal
https://finance.yahoo.com/m/59eba1a4-27b9-3668-a55e-d587e45e8901/arrowhead%2C-sarepta-skyrocket.html

Arrowhead Pharmaceuticals Fiscal Q4 Loss Widens, Revenue Declines
https://finance.yahoo.com/news/arrowhead-pharmaceuticals-fiscal-q4-loss-212818404.html

Arrowhead Pharma, Sarepta TX ink new gene therapy deal
https://finance.yahoo.com/video/arrowhead-pharma-sarepta-tx-ink-210555672.html

Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results
https://finance.yahoo.com/news/arrowhead-pharmaceuticals-reports-2024-fiscal-210000917.html

Sector Update: Health Care
https://finance.yahoo.com/news/sector-health-care-183114132.html

Yahoo Finance

Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 Billion Deal

Shares of Arrowhead Pharmaceuticals catapulted Tuesday after the company inked a broad licensing deal with Sarepta Therapeutics.

176 views00:06

🇺🇸 US 실적속보 by TNBfolio

241127일 US 기업 TP 정리

Upgrades

#APD #ADSK #ADSK #BOH #BURL #BURL #CRWD #DELL #DFS #DASH #DASH #EXAS #GEV #HCAT #HPQ #MRVL #MLM #JWN #JWN #JWN #NTNX #NTNX #NVDA #SPOT #TMUS #URBN #WDAY #WDAY

Downgrades

#ARE #ARWR #BC #DELL #DELL #XOM #HPQ #KSS #KSS #LULU #SRPT #SRPT #WDAY #WDAY #WDAY

https://naver.me/GHvlVmQL

(자세한 내용은 링크 참조)

Naver

241127 US 기업 TP 정리

485 views14:36

🇺🇸 US 실적속보 by TNBfolio

11월 28일 외사 기업 리포트

1. Philip Morris International (#PM)
- Goldman Sachs
- 무연 담배 제품의 시장 확대와 성장 잠재력으로 목표가 $150 유지, Buy 등급 지속

2. Amazon (#AMZN)
- Piper Sandler
- 2025년까지 물류 및 네트워크 전략 발전을 바탕으로 목표가 $225 유지, Overweight 등급 지속

3. Amazon (#AMZN)
- BofA Securities
- 물류 확장과 광고 및 AWS 부문 성장이 기대되며 Buy 등급 유지

4. Arrowhead Pharmaceuticals (#ARWR)
- Piper Sandler
- Sarepta와의 파트너십 및 RNAi 치료제 개발 가능성을 반영해 목표가 $62 -> $45로 조정, Overweight 등급 유지

5. Dell Technologies Inc. (#DELL)
- Citi
- 분기 실적 하락에도 AI와 PC 시장 회복 전망으로 목표가 $160 -> $156로 하향, Buy 등급 유지

6. Dell Technologies Inc. (#DELL)
- Mizuho
- AI 서버 및 PC 리프레시 사이클의 긍정적 영향으로 목표가 $155 -> $150로 하향, Outperform 등급 유지

https://naver.me/GYC1wejU

(자세한 내용은 링크 참조)

Naver

11월 28일 외사 기업 리포트

908 views16:27

🇺🇸 US 실적속보 by TNBfolio

Arrowhead Pharmaceuticals, Inc. (ARWR)
시가총액: 2.50B
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://arrowheadpharma.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2412: 2.5M / 74.42M / -96.6% / -29.6% / -92.9%
2409: 35M / 55.07M / -36.4% / 117.4% / -30.0%
2406: 50M / 52.87M / -5.4% / 216.0% / --
2403: 0.0 / -- / -- / -100.0% / -100.0%
2312: 3.55M / -- / -- / -- / -77.9%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2412: -1.39 / -0.39 / -256.4% / -12.1% / -2.2%
2409: -1.36 / -0.9704 / -40.1% / -- / 1.4%
2406: -1.38 / -0.53 / -160.4% / -43.7% / -35.3%
2403: -1.02 / -- / -- / -326.7% / 17.7%
2312: -1.24 / -- / -- / -217.9% / --

- 연간 매출(YoY%), EPS(YoY%)
2309: 240.74M(-1.0%) / -1.92(-15.0%)
2209: 243.23M(75.9%) / -1.67(-22.8%)
2109: 138.29M(57.2%) / -1.36(-61.9%)
2009: 87.99M(--) / -0.84(--)

#ARWR

- 사업요약: Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes Plozasiran...

46 views21:17

🇺🇸 US 실적속보 by TNBfolio

#ARWR

Arrowhead Closes Licensing, Collaboration Agreement With Sarepta
https://finance.yahoo.com/news/arrowhead-closes-licensing-collaboration-agreement-143734079.html

Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics
https://finance.yahoo.com/news/arrowhead-pharmaceuticals-announces-closing-global-133000678.html

Guidewire Software to Join S&P MidCap 400, Arrowhead Pharmaceuticals to Move to S&P SmallCap 600
https://finance.yahoo.com/news/guidewire-software-join-p-midcap-105056876.html

Guidewire Software Set to Join S&P MidCap 400; Arrowhead Pharmaceuticals to Join S&P SmallCap 600
https://finance.yahoo.com/news/guidewire-software-set-join-p-225400503.html

Arrowhead Pharmaceuticals to Webcast Fiscal 2025 First Quarter Results
https://finance.yahoo.com/news/arrowhead-pharmaceuticals-webcast-fiscal-2025-210000179.html

Yahoo Finance

Arrowhead Closes Licensing, Collaboration Agreement With Sarepta

Arrowhead Pharmaceuticals (ARWR) said Monday it has closed its licensing and collaboration agreement

36 views21:17

🇺🇸 US 실적속보 by TNBfolio

Arrowhead Pharmaceuticals, Inc. (ARWR)
시가총액: 1.77B
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://arrowheadpharma.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 542.71M / 127.9M / 324.3% / -- / 21608.4%
2412: 2.5M / 74.42M / -96.6% / -29.6% / -92.9%
2409: 35M / 55.07M / -36.4% / 117.4% / -30.0%
2406: 50M / 52.87M / -5.4% / 216.0% / --
2403: 0.0 / -- / -- / -100.0% / -100.0%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: 2.75 / -0.45 / 711.1% / 369.6% / 297.8%
2412: -1.39 / -0.39 / -256.4% / -12.1% / -2.2%
2409: -1.36 / -0.9704 / -40.1% / -- / 1.4%
2406: -1.38 / -0.53 / -160.4% / -43.7% / -35.3%
2403: -1.02 / -- / -- / -326.7% / 17.7%

- 연간 매출(YoY%), EPS(YoY%)
2309: 240.74M(-1.0%) / -1.92(-15.0%)
2209: 243.23M(75.9%) / -1.67(-22.8%)
2109: 138.29M(57.2%) / -1.36(-61.9%)
2009: 87.99M(--) / -0.84(--)

#ARWR

- 사업요약: Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipelin...

36 views20:17

About

Blog

Apps

Platform